Monoclonal antibody treatments are saving lives from COVID-19 and helps keep patients out of Triangle hospitals. Doctors are infusing newly diagnosed COVID-19 patients with antibodies that have been ...

The pause affects Sotrovimab from GlaxoSmithKline. The federal government is sharply pulling back on one of the monoclonal antibody treatments authorized for COVID-19, pausing its use across eight ...

The expanded authorization was based on data from the phase 2/3 BLAZE-1 trial. The Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab plus ...

PHILADELPHIA (WPVI) -- It's the only authorized treatment that can help keep people with COVID-19 out of the hospital, but hundreds-of-thousands of doses aren't being used. The effectiveness of ...

Both intravenous (IV) and intramuscular (IM) administration of the monoclonal antibody tixagevimab/cilgavimab rapidly eliminated culturable SARS-CoV-2, with both ...

(The Hill) — Evusheld, the preventative monoclonal antibody treatment for COVID-19, has lost its emergency use authorization in the U.S. as it is most likely not effective against the strains of the ...

Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...

JACKSONVILLE, Fla. -- Toma Dean had been in and out of the emergency room for the past two weeks, "extremely sick" with COVID-19, when she arrived at a Jacksonville, Florida, monoclonal antibody ...

Nov 17 (Reuters) - U.S. hospitals, weighing high demand and tight supplies, said they may limit use of a new Eli Lilly and Co (LLY.N), opens new tab antibody drug to COVID-19 patients with multiple ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...